Infections caused by
Staphylococcus aureus
are a leading cause of mortality worldwide.
S. aureus
infections caused by methicillin-resistant
Staphylococcus aureus
(MRSA) are particularly difficult to treat due to their resistance to next-generation β-lactams (NGBs) such as methicillin, nafcillin, and oxacillin. Resistance to NGBs, which is alternatively known as broad-spectrum β-lactam resistance, is classically mediated by PBP2a, a penicillin-binding protein encoded by
mecA
(or
mecC
) in MRSA. Thus, presence of
mec
genes among
S. aureus
spp. serves as the predictor of resistance to NGBs and facilitates determination of the proper therapeutic strategy for a staphylococcal infection. Although far less appreciated,
mecA
-deficient
S. aureus
strains can also exhibit NGB resistance. These strains, which are collectively termed as methicillin-resistant lacking
mec
(MRLM), are currently being identified in increasing numbers among natural resistant isolates of
S. aureus
. The mechanism/s through which MRLMs produce resistance to NGBs remains unknown. In this study, we demonstrate that mutations that alter PBP4 and GdpP functions, which are often present among MRLMs, can synergistically mediate resistance to NGBs. Furthermore, our results unravel that this novel mechanism potentially enables MRLMs to produce resistance toward NGBs at levels comparable to those of MRSAs. Our study provides a fresh new perspective about alternative mechanisms of NGB resistance, challenging our current overall understanding of high-level, broad-spectrum β-lactam resistance in
S. aureus
. It thus suggests reconsideration of the current approach toward diagnosis and treatment of β-lactam-resistant
S. aureus
infections.
IMPORTANCE
In
Staphylococcus aureus
, high-level, broad-spectrum resistance to β-lactams such as methicillin, also referred to as methicillin resistance, is largely attributed to
mecA
. This study demonstrates that
S. aureus
strains that lack
mecA
but contain mutations that functionally alter PBP4 and GdpP can also mediate high-level, broad-spectrum resistance to β-lactams. Resistance brought about by the synergistic action of functionally altered PBP4 and GdpP was phenotypically comparable to that displayed by
mecA
, as seen by increased bacterial survival in the presence of β-lactams. An analysis of mutations detected in naturally isolated strains of
S. aureus
revealed that a significant proportion of them had similar
pbp4
and
G
GDEF
d
omain
p
rotein containing
p
hosphodiesterase (
gdpP
) mutations, making this study clinically significant. This study not only identifies important players of non-classical mechanisms of β-lactam resistance but also indicates reconsideration of current clinical diagnosis and treatment protocols of
S. aureus
infections.